Comparison of maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis

Relationship with maternal treatment

R. S. Chhabra, L. P. Brion, M. Castro, L. Freundlich, J. H. Glaser

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The incidence of congenital syphilis has increased rapidly over the past few years. Most infected mothers and their newborns are asymptomatic at birth and diagnosis depends on serologic testing during pregnancy and at delivery. This study was initiated to compare maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis and to assess the role of maternal treatment (administration of penicillin to the mother at least 1 month before delivery) on the serologic results at the time of delivery. The serologic results from all live deliveries complicated by a positive maternal and/or neonatal test for syphilis during a 12-month period were compared using χ2 analysis and multiple comparisons for proportions. Of 3306 livebirths, 73 (2.2%) were complicated by a positive maternal or neonatal serology. At delivery, the serologic test was positive in 68 (94%) of 72 maternal sera, 30 (50%) of 60 cord sera, and 43 (63%) of 68 neonatal sera. In the absence of maternal treatment, 95% of the maternal sera, 66% of the cord blood samples, and 86% of the neonatal sera were positive. If the mother had been treated, 94% of maternal sera, 36% of cord sera, and 39% of neonatal sera were positive. Cord blood and neonatal sera appear to be inferior to maternal sera for detecting prenatal exposure to syphilis. Cord serology is also inferior to neonatal serology at 2 to 3 days of age. The most effective way to identify newborns at risk for congenital syphilis is to obtain a maternal serologic diagnosis during pregnancy and to test maternal and neonatal sera at delivery.

Original languageEnglish (US)
Pages (from-to)88-91
Number of pages4
JournalPediatrics
Volume91
Issue number1 I
StatePublished - 1993

Fingerprint

Congenital Syphilis
Fetal Blood
Mothers
Serum
Serology
Syphilis
Pregnancy Tests
Serologic Tests
Penicillins

Keywords

  • congenital syphilis
  • newborn
  • serodiagnosis
  • serology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Comparison of maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis : Relationship with maternal treatment. / Chhabra, R. S.; Brion, L. P.; Castro, M.; Freundlich, L.; Glaser, J. H.

In: Pediatrics, Vol. 91, No. 1 I, 1993, p. 88-91.

Research output: Contribution to journalArticle

@article{79ae7a93af774d37be2b7debff534e7e,
title = "Comparison of maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis: Relationship with maternal treatment",
abstract = "The incidence of congenital syphilis has increased rapidly over the past few years. Most infected mothers and their newborns are asymptomatic at birth and diagnosis depends on serologic testing during pregnancy and at delivery. This study was initiated to compare maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis and to assess the role of maternal treatment (administration of penicillin to the mother at least 1 month before delivery) on the serologic results at the time of delivery. The serologic results from all live deliveries complicated by a positive maternal and/or neonatal test for syphilis during a 12-month period were compared using χ2 analysis and multiple comparisons for proportions. Of 3306 livebirths, 73 (2.2{\%}) were complicated by a positive maternal or neonatal serology. At delivery, the serologic test was positive in 68 (94{\%}) of 72 maternal sera, 30 (50{\%}) of 60 cord sera, and 43 (63{\%}) of 68 neonatal sera. In the absence of maternal treatment, 95{\%} of the maternal sera, 66{\%} of the cord blood samples, and 86{\%} of the neonatal sera were positive. If the mother had been treated, 94{\%} of maternal sera, 36{\%} of cord sera, and 39{\%} of neonatal sera were positive. Cord blood and neonatal sera appear to be inferior to maternal sera for detecting prenatal exposure to syphilis. Cord serology is also inferior to neonatal serology at 2 to 3 days of age. The most effective way to identify newborns at risk for congenital syphilis is to obtain a maternal serologic diagnosis during pregnancy and to test maternal and neonatal sera at delivery.",
keywords = "congenital syphilis, newborn, serodiagnosis, serology",
author = "Chhabra, {R. S.} and Brion, {L. P.} and M. Castro and L. Freundlich and Glaser, {J. H.}",
year = "1993",
language = "English (US)",
volume = "91",
pages = "88--91",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1 I",

}

TY - JOUR

T1 - Comparison of maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis

T2 - Relationship with maternal treatment

AU - Chhabra, R. S.

AU - Brion, L. P.

AU - Castro, M.

AU - Freundlich, L.

AU - Glaser, J. H.

PY - 1993

Y1 - 1993

N2 - The incidence of congenital syphilis has increased rapidly over the past few years. Most infected mothers and their newborns are asymptomatic at birth and diagnosis depends on serologic testing during pregnancy and at delivery. This study was initiated to compare maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis and to assess the role of maternal treatment (administration of penicillin to the mother at least 1 month before delivery) on the serologic results at the time of delivery. The serologic results from all live deliveries complicated by a positive maternal and/or neonatal test for syphilis during a 12-month period were compared using χ2 analysis and multiple comparisons for proportions. Of 3306 livebirths, 73 (2.2%) were complicated by a positive maternal or neonatal serology. At delivery, the serologic test was positive in 68 (94%) of 72 maternal sera, 30 (50%) of 60 cord sera, and 43 (63%) of 68 neonatal sera. In the absence of maternal treatment, 95% of the maternal sera, 66% of the cord blood samples, and 86% of the neonatal sera were positive. If the mother had been treated, 94% of maternal sera, 36% of cord sera, and 39% of neonatal sera were positive. Cord blood and neonatal sera appear to be inferior to maternal sera for detecting prenatal exposure to syphilis. Cord serology is also inferior to neonatal serology at 2 to 3 days of age. The most effective way to identify newborns at risk for congenital syphilis is to obtain a maternal serologic diagnosis during pregnancy and to test maternal and neonatal sera at delivery.

AB - The incidence of congenital syphilis has increased rapidly over the past few years. Most infected mothers and their newborns are asymptomatic at birth and diagnosis depends on serologic testing during pregnancy and at delivery. This study was initiated to compare maternal sera, cord blood, and neonatal sera for detecting presumptive congenital syphilis and to assess the role of maternal treatment (administration of penicillin to the mother at least 1 month before delivery) on the serologic results at the time of delivery. The serologic results from all live deliveries complicated by a positive maternal and/or neonatal test for syphilis during a 12-month period were compared using χ2 analysis and multiple comparisons for proportions. Of 3306 livebirths, 73 (2.2%) were complicated by a positive maternal or neonatal serology. At delivery, the serologic test was positive in 68 (94%) of 72 maternal sera, 30 (50%) of 60 cord sera, and 43 (63%) of 68 neonatal sera. In the absence of maternal treatment, 95% of the maternal sera, 66% of the cord blood samples, and 86% of the neonatal sera were positive. If the mother had been treated, 94% of maternal sera, 36% of cord sera, and 39% of neonatal sera were positive. Cord blood and neonatal sera appear to be inferior to maternal sera for detecting prenatal exposure to syphilis. Cord serology is also inferior to neonatal serology at 2 to 3 days of age. The most effective way to identify newborns at risk for congenital syphilis is to obtain a maternal serologic diagnosis during pregnancy and to test maternal and neonatal sera at delivery.

KW - congenital syphilis

KW - newborn

KW - serodiagnosis

KW - serology

UR - http://www.scopus.com/inward/record.url?scp=0027497483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027497483&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 88

EP - 91

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1 I

ER -